X'PROCHEM is a biotech company that excels in custom protein synthesis, leveraging its proprietary chemical technology platform to assist bio-pharmaceutical partners in creating proteins tailored to their specific needs. The company’s innovative approach bypasses the limitations of classical recombinant methods, allowing for the synthesis of proteins of up to 400 amino acids (40 kD) in a safe, precise, and automated manner. X'PROCHEM aims to support scientists in accelerating their therapeutic, vaccine, and diagnostic projects, aligning with their vision of optimising both current and future biopharmaceutical products to enhance accessibility for preclinical and clinical use.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- High purity proteins
- Recombinant protein synthesis
- Custom protein production
- Peptide synthesis
- Hormone production
- Enzymes synthesis
- Cytokines production
- Biosimilars development
- Therapeutic proteins
- Diagnostic proteins
- Drug discovery support
- Chemical production

X'PROCHEM is dedicated to advancing the field of biopharmaceuticals through its cutting-edge services, ensuring the delivery of high-quality products that meet the demands of the pharmaceutical industry. For more information, please visit xprochem.com.